5-(5,6-dihydro-1,4-dioxin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate, 95.0%, 1g

4-Bromomethyl-1-fluoro-2-methoxy-benzene, 95.0%, 100mg

(R)-2-Aminodecanoic acid, 95%, 250mg

6-Fluoronaphthalen-1-amine, 98%, 250mg

5H-Pyrrolo[2,3-b]pyrazine-6-carboxylic acid, 95.0%, 1g

METHYL 3-METHYLMORPHOLINE-3-CARBOXYLATE HCL, 95.0%, 500mg

1-(piperidine-4-carbonyl)piperidin-4-one hydrochloride, 95.0%, 1g

N-(4-(4-(Trifluoromethoxy)phenyl)pyrimidin-2-yl)-1H-indazol-5-amine, 98+%, 25mg

5-Bromo-4-methylpyridine-2-carboxylic acid, 95.0%, 5g

Sodium acetate solution, 0.1 mol/l - 0.1 N standard solution in acetic acid, 1 l, plastic packaging.

(R)-4-(tert-Butyl)-2-(2-chloro-6-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 97%, 1g

3-(3-(Cyclopentylthio)-5-(((2-methyl-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)oxy)methyl)-4H-1,2,4-triazol-4-yl)pyridine, 98%, 50mg